ASPIRE BIOPHARMA HOLDINGS, INC. (ASBP) Scorecard
- 2026-Q2: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Lose; Revenue growth Lose; EPS growth Lose.
4/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 1 wins, 11 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q21/3 |
WinASBP / S&P 418.45% / 15.20% |
LoseASBP / S&P ASBP unavailable / 15.00% |
LoseASBP / S&P -93.19% / 50.40% |
| 2026-Q10/3 |
LoseASBP / S&P -80.49% / -4.33% |
LoseASBP / S&P ASBP unavailable / 11.30% |
LoseASBP / S&P ASBP unavailable / 27.70% |
| 2025-Q40/3 |
LoseASBP / S&P -35.92% / 2.65% |
LoseASBP / S&P ASBP unavailable / 9.00% |
LoseASBP / S&P ASBP unavailable / 13.40% |
| 2025-Q30/3 |
LoseASBP / S&P -23.42% / 8.12% |
LoseASBP / S&P ASBP unavailable / 4.61% |
LoseASBP / S&P ASBP unavailable / 13.45% |
| 2025-Q20/3 |
LoseASBP / S&P -53.86% / 10.94% |
LoseASBP / S&P ASBP unavailable / 4.83% |
LoseASBP / S&P ASBP unavailable / 10.63% |
| 2025-Q10/3 |
LoseASBP / S&P -94.93% / -4.27% |
LoseASBP / S&P ASBP unavailable / 4.98% |
LoseASBP / S&P ASBP unavailable / 10.57% |
| 2024-Q40/3 |
LoseASBP / S&P -5.81% / 2.41% |
LoseASBP / S&P ASBP unavailable / 5.25% |
LoseASBP / S&P ASBP unavailable / 6.15% |
| 2024-Q31/3 |
WinASBP / S&P 8.34% / 5.89% |
LoseASBP / S&P ASBP unavailable / 5.89% |
LoseASBP / S&P ASBP unavailable / 6.11% |
| 2024-Q20/3 |
LoseASBP / S&P 2.32% / 4.28% |
LoseASBP / S&P ASBP unavailable / 5.38% |
LoseASBP / S&P ASBP unavailable / 5.12% |
| 2024-Q10/3 |
LoseASBP / S&P 1.15% / 10.56% |
LoseASBP / S&P ASBP unavailable / 5.71% |
LoseASBP / S&P ASBP unavailable / 5.59% |
| 2023-Q40/3 |
LoseASBP / S&P 0.55% / 11.69% |
LoseASBP / S&P ASBP unavailable / 6.81% |
LoseASBP / S&P ASBP unavailable / 7.78% |
| 2023-Q31/3 |
WinASBP / S&P 3.93% / -3.27% |
LoseASBP / S&P ASBP unavailable / 7.52% |
LoseASBP / S&P ASBP unavailable / -5.03% |
| 2023-Q20/3 |
LoseASBP / S&P -0.76% / 8.74% |
LoseASBP / S&P ASBP unavailable / 9.50% |
LoseASBP / S&P ASBP unavailable / -8.57% |
| 2023-Q10/3 |
LoseASBP / S&P 1.94% / 7.50% |
LoseASBP / S&P ASBP unavailable / 10.77% |
LoseASBP / S&P ASBP unavailable / -15.69% |
| 2022-Q40/3 |
LoseASBP / S&P 1.58% / 7.56% |
LoseASBP / S&P ASBP unavailable / 11.88% |
LoseASBP / S&P ASBP unavailable / -17.99% |
| 2022-Q31/3 |
WinASBP / S&P 1.60% / -4.88% |
LoseASBP / S&P ASBP unavailable / 13.47% |
LoseASBP / S&P ASBP unavailable / -1.41% |
| 2022-Q20/3 |
LoseASBP / S&P ASBP unavailable / -16.10% |
LoseASBP / S&P ASBP unavailable / 13.71% |
LoseASBP / S&P ASBP unavailable / 11.04% |
| 2022-Q10/3 |
LoseASBP / S&P ASBP unavailable / -4.60% |
LoseASBP / S&P ASBP unavailable / 15.97% |
LoseASBP / S&P ASBP unavailable / 42.23% |
| 2021-Q40/3 |
LoseASBP / S&P ASBP unavailable / 11.03% |
LoseASBP / S&P ASBP unavailable / 15.00% |
LoseASBP / S&P ASBP unavailable / 96.40% |
| 2021-Q30/3 |
LoseASBP / S&P ASBP unavailable / 0.58% |
LoseASBP / S&P ASBP unavailable / 10.77% |
LoseASBP / S&P ASBP unavailable / 69.42% |
| 2021-Q20/3 |
LoseASBP / S&P ASBP unavailable / 8.55% |
LoseASBP / S&P ASBP unavailable / 6.58% |
LoseASBP / S&P ASBP unavailable / 51.81% |
| 2021-Q10/3 |
LoseASBP / S&P ASBP unavailable / 6.17% |
LoseASBP / S&P ASBP unavailable / -1.06% |
LoseASBP / S&P ASBP unavailable / 7.39% |
| 2020-Q40/3 |
LoseASBP / S&P ASBP unavailable / 12.15% |
LoseASBP / S&P ASBP unavailable / -3.72% |
LoseASBP / S&P ASBP unavailable / -33.42% |
| 2020-Q30/3 |
LoseASBP / S&P ASBP unavailable / 8.93% |
LoseASBP / S&P ASBP unavailable / -2.04% |
LoseASBP / S&P ASBP unavailable / -27.10% |
| 2020-Q20/3 |
LoseASBP / S&P ASBP unavailable / 20.54% |
LoseASBP / S&P ASBP unavailable / -0.46% |
LoseASBP / S&P ASBP unavailable / -27.11% |
| 2020-Q10/3 |
LoseASBP / S&P ASBP unavailable / -19.60% |
LoseASBP / S&P ASBP unavailable / 3.47% |
LoseASBP / S&P ASBP unavailable / -14.75% |
| 2019-Q40/3 |
LoseASBP / S&P ASBP unavailable / 9.07% |
LoseASBP / S&P ASBP unavailable / 5.36% |
LoseASBP / S&P ASBP unavailable / 2.99% |
| 2019-Q30/3 |
LoseASBP / S&P ASBP unavailable / 1.70% |
LoseASBP / S&P ASBP unavailable / 5.02% |
LoseASBP / S&P ASBP unavailable / 0.21% |
| 2019-Q20/3 |
LoseASBP / S&P ASBP unavailable / 4.30% |
LoseASBP / S&P ASBP unavailable / 6.64% |
LoseASBP / S&P ASBP unavailable / 8.65% |
| 2019-Q10/3 |
LoseASBP / S&P ASBP unavailable / 13.65% |
LoseASBP / S&P ASBP unavailable / 8.12% |
LoseASBP / S&P ASBP unavailable / 14.29% |
| 2018-Q40/3 |
LoseASBP / S&P ASBP unavailable / -13.52% |
LoseASBP / S&P ASBP unavailable / 9.05% |
LoseASBP / S&P ASBP unavailable / 18.23% |
| 2018-Q30/3 |
LoseASBP / S&P ASBP unavailable / 7.71% |
LoseASBP / S&P ASBP unavailable / 10.21% |
LoseASBP / S&P ASBP unavailable / 19.06% |
| 2018-Q20/3 |
LoseASBP / S&P ASBP unavailable / 3.43% |
LoseASBP / S&P ASBP unavailable / 9.03% |
LoseASBP / S&P ASBP unavailable / 14.46% |
| 2018-Q10/3 |
LoseASBP / S&P ASBP unavailable / -0.76% |
LoseASBP / S&P ASBP unavailable / 7.68% |
LoseASBP / S&P ASBP unavailable / 12.46% |
| 2017-Q40/3 |
LoseASBP / S&P ASBP unavailable / 6.64% |
LoseASBP / S&P ASBP unavailable / 7.03% |
LoseASBP / S&P ASBP unavailable / 13.82% |
| 2017-Q30/3 |
LoseASBP / S&P ASBP unavailable / 4.48% |
LoseASBP / S&P ASBP unavailable / 5.68% |
LoseASBP / S&P ASBP unavailable / 17.57% |
| 2017-Q20/3 |
LoseASBP / S&P ASBP unavailable / 3.09% |
LoseASBP / S&P ASBP unavailable / 4.83% |
LoseASBP / S&P ASBP unavailable / 17.74% |
| 2017-Q10/3 |
LoseASBP / S&P ASBP unavailable / 6.07% |
LoseASBP / S&P ASBP unavailable / 3.67% |
LoseASBP / S&P ASBP unavailable / 13.32% |
| 2016-Q40/3 |
LoseASBP / S&P ASBP unavailable / 3.82% |
LoseASBP / S&P ASBP unavailable / 2.09% |
LoseASBP / S&P ASBP unavailable / 7.05% |
| 2016-Q30/3 |
LoseASBP / S&P ASBP unavailable / 3.85% |
LoseASBP / S&P ASBP unavailable / 0.20% |
LoseASBP / S&P ASBP unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | ASBP total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -64.09% | 20.78% |
| Annualized return | -64.09% | 20.78% |
5Y · 2022-04-11 to 2026-08-27
| Metric | ASBP total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -97.93% | 83.14% |
| Annualized return | -53.97% | 12.86% |
10Y · 2022-04-11 to 2026-08-27
| Metric | ASBP total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -97.93% | 319.30% |
| Annualized return | -32.15% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B |